Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fantin

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|June 29, 2013
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerationsTiphaine Goulenok, Bruno Fantin
Clinical Pharmacokinetics|August 30, 2017
Pharmacokinetics and Pharmacodynamics of TemocillinKevin Alexandre, Bruno Fantin
Future Microbiology|June 30, 2015
Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistanceVictoire de Lastours, Bruno Fantin
La Revue Du Praticien|June 14, 2014
[Infections associated with orthopaedic devices]Vincent Dubée, Valérie Zeller, Bruno Fantin
Antimicrobial Agents and Chemotherapy|July 29, 2009
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infectionNicolas Allou, Emmanuelle Cambau, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strainsFrançoise Chau, Agnès Lefort, Samira Benadda, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplaninAgnès Lefort, Juliette Pavie, Louis Garry, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureusClaudette Muller-Serieys, Azzam Saleh Mghir, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faeciumAgnès Lefort, Louis Garry, Florence Depardieu, et al.
European Cytokine Network|April 3, 2007
Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniaeJacqueline Mohler, Pierre Moine, Esther Azoulay-Dupuis, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|June 29, 2013
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerationsTiphaine Goulenok, Bruno Fantin
Clinical Pharmacokinetics|August 30, 2017
Pharmacokinetics and Pharmacodynamics of TemocillinKevin Alexandre, Bruno Fantin
Future Microbiology|June 30, 2015
Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistanceVictoire de Lastours, Bruno Fantin
La Revue Du Praticien|June 14, 2014
[Infections associated with orthopaedic devices]Vincent Dubée, Valérie Zeller, Bruno Fantin
Antimicrobial Agents and Chemotherapy|July 29, 2009
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infectionNicolas Allou, Emmanuelle Cambau, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strainsFrançoise Chau, Agnès Lefort, Samira Benadda, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplaninAgnès Lefort, Juliette Pavie, Louis Garry, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureusClaudette Muller-Serieys, Azzam Saleh Mghir, Laurent Massias, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faeciumAgnès Lefort, Louis Garry, Florence Depardieu, et al.
European Cytokine Network|April 3, 2007
Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniaeJacqueline Mohler, Pierre Moine, Esther Azoulay-Dupuis, et al.
Pageof 11